Alpha 2.0
Login Register
» Authors » I Arijs

I Arijs

Explore the profile of I Arijs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 485
Followers 0
Related Specialties
Urology
Gastroenterology
Oncology
Top 10 Co-Authors
K Van Renterghem
F Van der Aa
E Baten
D Lambrechts
G Van Assche
H Goethuys
M Ferrante
F Schnitzler
K Van Steen
S Vermeire
Published In
Gut
World J Urol
Nat Commun
Ann Oncol
J Urol
Affiliations
Soon will be listed here.
Recent Articles
1.
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy
White K, Connor K, Meylan M, Bougouin A, Salvucci M, Bielle F, et al.
Ann Oncol . 2022 Dec; 34(3):300-314. PMID: 36494005
Background: New precision medicine therapies are urgently required for glioblastoma (GBM). However, to date, efforts to subtype patients based on molecular profiles have failed to direct treatment strategies. We hypothesised...
2.
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, et al.
Nat Commun . 2021 Jul; 12(1):4117. PMID: 34226537
Epidemiological and clinical reports indicate that SARS-CoV-2 virulence hinges upon the triggering of an aberrant host immune response, more so than on direct virus-induced cellular damage. To elucidate the immunopathology...
3.
A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB)
Baten E, Van der Aa F, Goethuys H, Slabbert K, Arijs I, Van Renterghem K
World J Urol . 2021 Apr; 39(10):3839-3844. PMID: 33839918
Purpose: To determine whether omitting antimicrobial prophylaxis (AMP) in TURB is safe in patients undergoing TURB without an indwelling pre-operative catheter/nephrostomy/DJ and a negative pre-operative urinary culture. Materials And Methods:...
4.
Antimicrobial Prophylaxis in Transurethral Resection of the Prostate: Results of a Randomized Trial
Baten E, Van der Aa F, Goethuys H, Slabbaert K, Arijs I, Van Renterghem K
J Urol . 2021 Feb; 205(6):1748-1754. PMID: 33560163
Purpose: We sought to determine whether omitting antimicrobial prophylaxis is safe in patients undergoing transurethral resection of the prostate without preoperative pyuria and a preoperative catheter. Materials And Methods: We...
5.
Antibiotic prophylaxis in TURP: a prospective analysis concerning antibiotic stewardship and a potential reduction of antibiotic use in TURP
Baten E, Van der Aa F, Orye C, Cartuyvels R, Arijs I, Van Renterghem K
World J Urol . 2019 Feb; 37(11):2467-2472. PMID: 30739131
Purpose: Antibiotic prophylaxis is standard procedure in transurethral resection of the prostate (TURP). We evaluated the necessity of antibiotic (AB) prophylaxis in TURP due to increasing microbial antibiotic resistance. Methods:...
6.
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
Arijs I, Li K, Toedter G, Quintens R, Van Lommel L, Van Steen K, et al.
Gut . 2009 Aug; 58(12):1612-9. PMID: 19700435
Background And Aims: Infliximab is an effective treatment for ulcerative colitis with over 60% of patients responding to treatment and up to 30% reaching remission. The mechanism of resistance to...
7.
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, et al.
Gut . 2008 Oct; 58(4):492-500. PMID: 18832518
Background And Aims: This observational study assessed the long-term clinical benefit of infliximab (IFX) in 614 consecutive patients with Crohn's disease (CD) from a single centre during a median follow-up...